{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:58:54Z","timestamp":1792191534822,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.lungcan.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T18:32:24Z","timestamp":1668882744000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study"],"prefix":"10.1016","volume":"175","author":[{"given":"Prakasit","family":"Sa-ngiamwibool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunimitsu","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.11.013_b0005","unstructured":"WHO Classification of Tumours Editorial Board, eds. Thoracic Tumours: WHO Classification of Tumours. 5th ed. Lyon: International Agency for Research on Cancer (IARC); 2021."},{"key":"10.1016\/j.lungcan.2022.11.013_b0010","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Lanphear","year":"1992","journal-title":"J. Occup. Med."},{"key":"10.1016\/j.lungcan.2022.11.013_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"33","author":"Popat","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A nuclear grading system is a strong predictor of survival in epithelioid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod. Pathol."},{"issue":"2018","key":"10.1016\/j.lungcan.2022.11.013_b0025","first-page":"89","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma. update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2022.11.013_b0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0035","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: New markers and how to use them","volume":"44","author":"Churg","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0040","doi-asserted-by":"crossref","unstructured":"D.B. Chapel J.J. Schulte A.N. Husain T. Krausz Application of immunohistochemistry in diagnosis and management of malignant mesothelioma Transl. Lung. Cancer Res. 9 Suppl 1 2020 pp S3\u2013S27.https:\/\/doi.org\/ 10.21037\/tlcr.2019.11.29.","DOI":"10.21037\/tlcr.2019.11.29"},{"key":"10.1016\/j.lungcan.2022.11.013_b0045","doi-asserted-by":"crossref","unstructured":"J. Hmeljak, F. Sanchez-Vega, K.A. Hoadley, J. Shih, C. Stewart, D. Heiman, P. Tarpey, L. Danilova, E. Drill, E.A. Gibb, R. Bowlby, R. Kanchi, H.U. Osmanbeyoglu, Y. Sekido, J. Takeshita, Y. Newton, K. Graim, M. Gupta, C.M. Gay, L. Diao, D.L. Gibbs, V. Thorsson, L. Iype, H. Kantheti, D.T. Severson, G. Ravegnini, P. Desmeules, A.A. Jungbluth, W.D. Travis, S. Dacic, L.R. Chirieac, F. Galateau-Salle, J. Fujimoto, A.N. Husain, H.C. Silveira, V.W. Rusch, R.C. Rintoul, H. Pass, H. Kindler, M.G. Zauderer, D.J. Kwiatkowski, R. Bueno, A.S. Tsao, J. Creaney, T. Lichtenberg, K. Leraas, J. Bowen, T.R. Network, I. Felau, J.C. Zenklusen, R. Akbani, A.D. Cherniack, L.A. Byers, M.S. Noble, J.A. Fletcher, A.G. Robertson, R. Shen, H. Aburatani, B.W. Robinson, P. Campbell, M. Ladanyi, Integrative molecular characterization of malignant pleural mesothelioma, Cancer Discov. 8 (2018) 1548-1565. .","DOI":"10.1158\/2159-8290.CD-18-0804"},{"key":"10.1016\/j.lungcan.2022.11.013_b0050","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/jcm10051034","article-title":"The evolving landscape of the molecular epidemiology of malignant pleural mesothelioma","volume":"10","author":"Lettieri","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lungcan.2022.11.013_b0055","doi-asserted-by":"crossref","first-page":"e20191257","DOI":"10.1084\/jem.20191257","article-title":"Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice","volume":"217","author":"Badhai","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lungcan.2022.11.013_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncy.22509","article-title":"Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology","volume":"130","author":"Girolami","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests","volume":"66","author":"Hida","year":"2016","journal-title":"Pathol. Int."},{"key":"10.1016\/j.lungcan.2022.11.013_b0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/pin.12973","article-title":"Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma","volume":"70","author":"Kinoshita","year":"2020","journal-title":"Pathol. Int."},{"key":"10.1016\/j.lungcan.2022.11.013_b0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2022.11.013_b0080","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/ijms19040988","article-title":"NF2\/Merlin inactivation and potential therapeutic targets in mesothelioma","volume":"19","author":"Sato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2022.11.013_b0085","doi-asserted-by":"crossref","unstructured":"G. Guo, J. Chmielecki, C. Goparaju, A. Heguy, I. Dolgalev, M. Carbone, S. Seepo, M. Meyerson, H.I. Pass, Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma, Cancer Res. 75(2015) 264-269. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1008.","DOI":"10.1158\/0008-5472.CAN-14-1008"},{"key":"10.1016\/j.lungcan.2022.11.013_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41379-019-0371-0","article-title":"Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma","volume":"33","author":"Brich","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41379-019-0309-6","article-title":"Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma","volume":"33","author":"Kinoshita","year":"2020","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.lungcan.2022.11.013_b0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/cncy.22409","article-title":"Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma","volume":"129","author":"Kinoshita","year":"2021","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0110","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2022.11.013_b0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/modpathol.2017.108","article-title":"Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma","volume":"31","author":"Vivero","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","volume":"65","author":"Takeda","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0125","doi-asserted-by":"crossref","first-page":"e2100422","DOI":"10.1200\/PO.21.00422","article-title":"Molecular characterization of mesothelioma: impact of histologic type and site of origin on molecular landscape","volume":"6","author":"Dagogo-Jack","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2022.06.008","article-title":"DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas","volume":"170","author":"Jurmeister","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2022.11.013_b0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.lungcan.2020.10.020","article-title":"Homozygous deletion of CDKN2A in malignant mesothelioma: Diagnostic utility, patient characteristics and survival in a UK mesothelioma centre","volume":"150","author":"Marshall","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2022.11.013_b0140","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2022.11.013_b0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cncy.22326","article-title":"Testing for BAP1 loss and CDKN2A\/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology","volume":"128","author":"Chevrier","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncy.22221","article-title":"Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"128","author":"Berg","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0160","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/cancers12092454","article-title":"Deep sequencing analysis identified a specific subset of mutations distinctive of biphasic malignant pleural mesothelioma","volume":"12","author":"Torricelli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2022.11.013_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anndiagpath.2016.10.010","article-title":"Usefulness of p16\/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma","volume":"26","author":"Wu","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0170","doi-asserted-by":"crossref","first-page":"1610322","DOI":"10.1080\/23723556.2019.1610322","article-title":"Unraveling the cellular heterogeneity of malignant pleural mesothelioma through a deconvolution approach","volume":"6","author":"Blum","year":"2019","journal-title":"Mol. Cell Oncol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0175","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/1878-0261.12651","article-title":"Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival","volume":"14","author":"Quetel","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0000000000001416","article-title":"Utility of nuclear grading system in epithelioid malignant pleural mesothelioma in biopsy-heavy setting: an external validation study of 563 cases","volume":"44","author":"Zhang","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/diagnostics10060386","article-title":"Prognostic value of Ki67 percentage, WT-1 expression and p16\/CDKN2A deletion in diffuse malignant peritoneal mesothelioma: a single-centre cohort study","volume":"10","author":"Pezzuto","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.lungcan.2022.11.013_b0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.2010.076794","article-title":"FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma","volume":"63","author":"Chung","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0195","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/bjc.2014.478","article-title":"Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales","volume":"111","author":"Linton","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2022.11.013_b0200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.pathol.2018.05.002","article-title":"Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications","volume":"50","author":"Forest","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.lungcan.2022.11.013_b0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2016.09.026","article-title":"BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma","volume":"60","author":"McGregor","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lungcan.2022.11.013_b0210","article-title":"Malignant mesothelioma, BAP1 immunohistochemistry, and VEGFA: Does BAP1 have potential for early diagnosis and assessment of prognosis?","volume":"2017","author":"Pulford","year":"2017","journal-title":"Dis. Mark."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:02:13Z","timestamp":1759237333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222006869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"alternative-id":["S0169500222006869"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.11.013","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}